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SUMMARY · The aim of the study was to determine the incidence of coagulation disorders and
possible differences between patients operated on for head and neck tumors with and without blood
transfusion treatment. The study included 31 patients divided into two groups: 16 patients with and
15 patients without intraoperative administration of blood transfusion. The following laboratory
parameters were monitored: leukocyte count, erythrocyte count, hemoglobin, hematocrit, platelet
count, activated partial thromboplastin time, prothrombin time, fibrinogen, thrombin time, and fi-
brinolysis. Data were statistically analyzed by Student’s t-test for dependent and independent samples,
and by simple correlation. The results showed prothrombin time to be statistically significantly re-
duced postoperatively in both patient groups, while fibrinolysis was statistically significantly acceler-
ated in the group of patients who received intraoperative blood transfusion. Accordingly, in patients
administered blood transfusion during the surgery, fibrinolysis was statistically significantly acceler-
ated in comparison with their preoperative values. In the group of patients who did not receive intra-
operative blood transfusion, fibrinolysis remained within the physiological range.
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Introduction
Radical operative procedure for extirpation of the lar-
ynx and pharynx as well as radical operations of the neck
with partial removal of the mandible are basic therapeu-
tic methods for malignant tumors of the neck and jaws.
The patients undergoing such operations mostly are at an
advanced age and suffer from many concomitant chronic
diseases, primarily chronic obstructive lung disease, liver
impairment, ischemic heart disease, and alcoholic and
nicotinic dependence. According to the estimated risk,
they belong to ASA II and ASA III groups. Besides pre-
operative examination and routine laboratory tests, pul-
monary function tests, arterial blood gases, cardiac func-
tion tests, proteinogram, coagulation tests and others are
included, depending on the coexistent chronic disease1.
Analysis of the laboratory findings thus obtained revealed
precipitated fibrinolysis in some patients, while the con-
centration of plasma fibrinogen was elevated in a major-
ity of patients. Increased concentration of fibrinogen and
accelerated fibrinolysis were most commonly observed,
and led to the introduction of mandatory monitoring of
basic coagulation tests in 31 patients. In addition to co-
agulation tests, the levels of erythrocytes, leukocytes, he-
moglobin, hematocrit and platelets were also observed.
These parameters were preoperatively and postoperatively
monitored and statistically analyzed.
The aim of the study was to determine the incidence
of coagulation disorders in patients operated on for ma-
lignant diseases of the head and neck, and to assess
changes in laboratory findings of patients with and with-
out intraoperative blood transfusion.
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Patients and Methods
The study included 31 patients divided into two
groups of 16 and 15 patients who did and did not receive
intraoperative blood transfusion, respectively. The follow-
ing laboratory parameters were preoperatively and post-
operatively monitored: leukocyte count (L), erythrocyte
count (E), hemoglobin (Hb), platelets (Plt), active partial
thromboplastin time (APTT), prothrombin time (PT),
fibrinogen, thrombin time (TT), and fibrinolysis. The
values of L, E, Hb and Plt were determined on an auto-
mated Counter Micro Diff 2 (Miami, FL, USA), while
APTT, PT and TT were determined by standard meth-
ods on an automated ALC 2000 coagulometer (IL-Instru-
mentation Laboratory). Fibrinogen was determined on
the same device by the method of Clauss. The test of eu-
globulin fibrinolysis was performed in water bath at 37 °C
by use of standard methods. Analyses were performed on
citrated plasma samples. The values thus obtained were
statistically analyzed by Student’s t-test for dependent and
independent samples, and by simple correlation.
Thirty minutes before the operation, the patients were
premedicated with 5 mg midazolam and 0.5 mg atropine
sulfate intramuscularly. Thiopental, etomidate or propofol
was used for general anesthesia induction, and anesthesia
was maintained by the administration of midazolam and
fentanyl, with ventilation with a mixture of oxide and ni-
trous oxide (FiO2 0.33). The use of general anesthetics
(halothane and isoflurane) was restricted to a small num-
ber of patients with specific respiratory disorders. Anes-
thesia was controlled by a Dräger Sulla 808V device
(Dräger, Lübeck, Germany), and duration of anesthesia
was between 3 and 8 hours.
Results
Laboratory test findings obtained before and after the
surgery in 31 patients operated on for planocellular car-
cinoma of the head and neck are presented in Table 1.
Postoperatively, a statistically significant increase in L, and
statistically significant decrease in E, Hb, Htc and Plt were
recorded, whereas APTT showed no statistically signifi-
cant alteration. Postoperative PT values were statistically
significantly decreased in comparison with preoperative
findings. No statistically significant change was recorded
for the values of fibrinogen and TT. Postoperatively, fi-
brinolysis was found to be statistically significantly pre-
cipitated, however, the mean values of fibrinolysis were
slightly below the normal physiological values and caused
no clinically relevant hemostatic disturbances such as
hemorrhage. Analysis of statistical results for 16 patients
with and 15 patients without intraoperative blood trans-
fusion (Tables 2 and 3) revealed a statistically significant
increase in L and a statistically significant decrease in E,
Hb and Htc in non-transfused patients. On the other
hand, no stastistically significant change was recorded for
E, Hb and Htc in transfused patients, i.e. their postop-
erative values remained almost unchanged, which was at-
tributed to the good anesthesiologist’s assessment of the
blood loss and replacement.
Table 1. Preoperative and postoperative values (mean ± SD) of labo-
ratory parameters in 31 patients obtained by Student’s t-test for de-
pendent samples
Parameter Preoperative Postoperative p
L 7.6±1.9 14.3±4.7 <0.0001
E 4.2±0.5 3.96±0.5 <0.005
Hb 131.9±14.4 122.8±12.2 <0.0002
Htc 0.40±0.05 0.38±0.04 <0.001
Plt 250.5±84.7 220.2±78.9 <0.003
APTT 35.0±4.3 32.7±5.4 NS
PT 104.2±15.8 92.2±14.9 <0.0001
Fibrinogen 4.7±1.5 4.8±1.5 NS
TT 17.8±2.0 17.7±2.3 NS
Fibrinolysis 185.3±37.0 140.6±74.0 <0.003
NS=non-significant
Table 2. Preoperative and postoperative values (mean ± SD) of labo-
ratory parameters in 16 patients receiving intraoperative blood
transfusion, obtained by Student’s t-test for dependent samples
Parameter Preoperative Postoperative p
L 7.25±2.12 14.86±5.0 <0.00002
E 4.03±0.38 4.02±0.41 NS
Hb 129.81±15.1 126.13±11.2 NS
Htc 0.39±0.04 0.38±0.04 NS
Plt 230.1±80.1 204.6±49.4 <0.04
APTT 33.9±3.7 32.2±4.0 NS
PT 109.3±16.2 96.0±15.3 <0.002
Fibrinogen 4.9±1.7 4.7±1.5 NS
TT 118.0±1.8 17.3±1.8 NS
Fibrinolysis 192.2±36.0 122.2±76.8 <0.01
NS=non-significant
Platelets showed a statistically significant decrease in
both groups of patients, as the result of intraoperative di-
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lution and hemostatic consumption4. Eight non-trans-
fused and four transfused patients had basal values of fi-
brinolysis below the normal limits. Statistical analysis of
correlation for individual parameters pointed to differ-
ences between the transfused and non-transfused patients.
Positive correlation in transfused patients (Table 4) and
negative correlation in non-transfused patients (Table 5)
was found for all parameters except for postoperative fi-
brinogen and fibrinolysis, which yielded positive correla-
tion.
Discussion and Conclusion
The results obtained were expected and could be ex-
plained by metabolic, endocrinologic, neurologic and im-
munologic response of the body to the operation, and in-
traoperative dilution, blood loss and hemostatic consump-
tion2-4. The reduced postoperative PT values could be in-
terpreted as intraoperative hemostatic consumption of the
prothrombin complex factors. The basal values of fibrino-
gen were elevated due to malignant disease, its growth and
central tumor necrosis activating considerably more mac-
rophages and enhancing the fibrinogen response and its
serum concentration increase. Elevated fibrinogen con-
centrations are found in smokers and in mild liver impair-
ment, because in these conditions the liver produces more
fibrinogen as a compensation. Most of our patients were
smokers and consumed more or less alcohol until the di-
agnosis of malignoma. Thrombosis and microembolism
associated with malignancy lead to hypercoagulability and
increased fibrinogen concentrations2,4. In our patients, the
following clinical parameters could have contributed to the
laboratory impairment of hemostasis: advanced age, fear
from the disease and operation, general condition (e.g.,
hypoventilation, liver diseases, etc.), length of operation
(major surgery), depth and type of anesthesia, intraopera-
tive hypothermia, size and type of tumor, number and dis-
semination of metastases, tumor relation with the adjacent
tissue, blood transfusion, amount of transfusion, type and
storage of blood preparations, thrombocytopenia in some
patients, etc.5,6.
Interactions between the neoplasm and hemostatic
system have long been known and numerous mechanisms
of this interaction have been investigated. The vascular
system within the tumor mass undergoes active rearrange-
ments with time, usually resulting in the formation of ir-
regular blood compartments, frequently lacking endothe-
lium, which leads to direct contact between the blood and
basal membrane. Hemodynamically, the geometric resis-
tance frequently increases in intratumorous blood vessels,
thus hampering the blood flow3. Tumor cells may release
procoagulant activators such as tissue factor (TF), tumor
procoagulant CP, prothrombin activators, thrombin acti-
vators, tissue specific proteases, cytokines and plasmino-
gen activator inhibitors5. On the other hand, the concen-
tration and synthesis of coagulation inhibitors (AT III,
Table 3. Preoperative and postoperative values (mean ± SD) of labo-
ratory parameters in 15 patients not receiving intraoperative blood
transfusion, obtained by Student’s t-test for dependent samples
Parameter Preoperative Postoperative p
L 7.97±1.72 13.63±4.23 <0.00008
E 4.4±0.5 3.91±0.53 <0.0003
Hb 134.07±3.71 119.2±12.67 <0.00001
Htc 0.42±0.05 0.37±0.04 <0.0003
Plt 272.3±86.6 236.9±100.7 <0.04
APTT 36.1±4.7 33.3±5.9 NS
PT 98.8±14.1 88.1±13.7 <0.02
Fibrinogen 4.5±1.2 4.8±1.6 NS
TT 17.5±2.2 18.1±2.7 NS
Fibrinolysis 178.0±38.2 160.3±67.7 NS
NS=non-significant
Table 4. Simple correlation of laboratory findings in 16 patients re-
ceiving intraoperative blood transfusion
Parameter                                        r                   p
L 0 · Plt 1 0.86 0.0002
Plt 0 · Plt 1 0.85 0.00003
Plt 0 · Fibrinogen 0 0.77 0.0005
PT 0 · PT 1 0.62 0.01
Fibrinogen 0 · Fibrinogen 1 0.50 0.05
0=preoperative value; 1=postoperative value
Table 5. Simple correlation of laboratory findings in 15 patients not
receiving intraoperative blood transfusion
Parameter                                        r                   p
L 2 · Htc 2 -0.82 0.0002
L 3 · Fibrinolysis 3 -0.53 0.04
E 3 · Fibrinolysis 3 -0.53 0.04
Fibrinogen 2 · Fibrinolysis 2 -0.53 0.04
Fibrinogen 3 · Fibrinolysis 3 0.52 0.05
2=preoperative value; 3=postoperative value
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protein C, protein S) and increased activity of plasmino-
gen activators may also cause hemostatic impairments in
these patients. These activities are most commonly in-
duced by tumors of the pancreas, gastrointestinal tract,
ovary, prostate, breast, lungs and liver5-7.
From the clinical viewpoint, the hemostatic impair-
ments associated with neoplasia include a wide range of
manifestations, from mild biological coagulation activity
through thrombosis, thromboembolism and hemorrhage.
No major coagulation disturbances in patients with and
operated for planocellular carcinoma of the head and neck
have been described in the literature. Betlejewski et al.
investigated the effect of laryngectomy on the process of
fibrinolysis in the blood of patients with laryngeal neo-
plasm. Their study has demonstrated that the increased
values of tissue plasminogen activator (t-PA) and fibrin
and fibrinogen breakdown products (FDB), decreased
values of plasminogen activation inhibitor 1 (PAI-1), and
low values of fibrinogen along with reduced euglobulin
lysis test (ELT) lead to the activation of fibrinolysis dur-
ing the procedure of laryngectomy8.
During the surgery, the patients received one or two
blood doses. No major hemorrhage or replacement of
blood or blood products were recorded in the patients.
According to current concepts, an acute blood loss of 10%
of the total volume of circulating blood and replacement
of this blood volume should not be expected to cause any
impairments in primary hemostasis dependent on plate-
lets, coagulation and fibrinolysis9. According to the re-
ports from animal experiments (rabbits), acute losses of
20% of total volume of circulating blood produce signifi-
cant clotting time reduction without any discernible
changes in primary hemostasis and fibrinolysis. However,
if these losses are accompanied by blood transfusion, the
coagulation time and time to the formation of the first he-
mostatic clot occur without any change in the fibrinoly-
sis10. In our patients, enhanced hemorrhage and, conse-
quently, intraoperative blood transfusion were most prob-
ably caused by lower basal values of E, Hb and Htc; ma-
jor surgery implying prolonged duration of the procedure;
tumor size and localization; number and dissemination of
metastases; and surgeon’s skill, rather than by a coagula-
tion system impairment. In the patients with intraopera-
tive blood transfusion, the precipitated fibrinolysis prob-
ably resulted from higher fibrinolytic activity, elevated fi-
brinogen concentration, or >14-day storage of the trans-
fused blood with an increased content of platelet, leuko-
cyte and fibrin degradation.
The results of the study pointed to the following con-
clusions: 1) basal values of precipitated fibrinolysis do not
appear to predict for enhanced intraoperative hemorrhage
and transfusion; 2) planocellular carcinomas of the head
and neck induce mild hypercoagulation; 3) the hyper-
coagulant changes did not cause any severe clinical com-
plications of coagulation such as thrombosis, thromboem-
bolism, or hemorrhage; 4) elevated concentrations of fi-
brinogen might correlate with advanced disease, thus also
likely with further prognosis; and 5) precipitated fibrin-
olysis in transfused patients was probably due to the trans-
fused blood storage of >14 days.
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Saæetak
SPECIFI»NOSTI HEMATOLO©KIH LABORATORIJSKIH NALAZA KOD VELIKIH ZAHVATA TUMORA
GLAVE I VRATA
J. KovaË, M. PeriÊ, S. Martinac-Djulepa, M. IvkiÊ, V. StanËiÊ, B. RaiÊ, D. TonkoviÊ, S. Krapinec i M. Novkoski
Cilj ispitivanja bio je utvrditi uËestalost poremeÊaja zgru¹avanja krvi u bolesnika operiranih zbog tumorskog procesa glave
i vrata, te moguÊu razliku izmeðu bolesnika koji su tijekom operacije primali transfuziju i onih koji to nisu. Ukupno je 31
bolesnik bio obuhvaÊen ispitivanjem. Bolesnici su bili podijeljeni u dvije skupine: 16 bolesnika je primalo transfuziju tijekom
operacijskog zahvata, a 15 bolesnika nije primalo transfuziju. PraÊeni su sljedeÊi laboratorijski parametri: broj leukocita, broj
eritrocita, hemoglobin, hematokrit, broj trombocita, aktivirano parcijalno tromboplastinsko vrijeme, protrombinsko vrijeme,
fibrinogen, trombinsko vrijeme i fibrinoliza. Podaci su bili statistiËki obraðeni Studentovim t-testom za zavisne i nezavisne
uzorke, te jednostavnom korelacijom. Rezultati su pokazali statistiËki znaËajno skraÊenje protrombinskog vremena nakon
operacije u objema skupinama, dok je fibrinoliza bila statistiËki znaËajno ubrzana u skupini bolesnika koji su primali transfuziju.
Dakle, u skupini bolesnika koji su primali transfuziju zabiljeæeno je statistiËki znaËajno ubrzanje fibrinolize nakon operacije
u usporedbi s prijeoperacijskim vrijednostima. U bolesnika koji nisu primali transfuziju fibrinoliza je ostala u fiziolo¹kim
granicama.
KljuËne rijeËi: Neoplazme glave i vrata, operacija; Neoplazme, krv; Fibrinoliza, fiziologija
